{"id":45732,"date":"2022-07-01T12:01:52","date_gmt":"2022-07-01T10:01:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/"},"modified":"2022-07-01T12:01:52","modified_gmt":"2022-07-01T10:01:52","slug":"stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/","title":{"rendered":"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\/Chronic Diseases Fueling Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5603759\/stents-technologies-and-global-markets-2022-2027?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=2922c6&amp;utm_campaign=1720326+-+Stents%3A+Technologies+and+Global+Markets+2022-2027%3A+Greater+Incidence+of+Non-Communicable%2FChronic+Diseases+Fueling+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Stents: Technologies and Global Markets 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220701005164\/en\/1503026\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220701005164\/en\/1503026\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027.\n<\/p>\n<p>\nThe global market for stents by vascular therapeutic application is estimated to increase from $7.1 billion in 2022 to $8.7 billion by 2027, at a CAGR of 4.2% during the forecast period of 2022 through 2027.\n<\/p>\n<p>\nThe global market for stents by nonvascular therapeutic application is estimated to increase from $760.4 million in 2022 to $970.5 million by 2027, at a CAGR of 5.0% during the forecast period of 2022 through 2027.\n<\/p>\n<p>\nThe global stents market is growing at a slow to moderate rate, with different devices on different swings. The peripheral vascular stents are on an upswing and are expected to see a high growth rate worldwide. U.S., Europe, and Japan are among the largest regions in terms of stents market share. These markets are reaching a point of saturation, where opportunity is focusing not on market penetration but rather on the opportunity to replace or shift to the newest generation of stents technology.\n<\/p>\n<p>\n<strong>Report Scope<\/strong>\n<\/p>\n<ul>\n<li>\nAn up-to-date review of the global markets for stents and associated medical device technologies\n<\/li>\n<li>\nAnalyses of the global market trends, with revenue sales data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027\n<\/li>\n<li>\nEvaluation and forecast of the global stents market size, forecasted growth trends, and corresponding market share analysis by product type, therapeutic application, and geographic region\n<\/li>\n<li>\nIdentification of promising new products (stents) and technologies that are still in development and assess the probability of their successful commercialization over the next few years\n<\/li>\n<li>\nIn-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of the global stents marketplace\n<\/li>\n<li>\nDiscussion of the regulatory structure for medical stents, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the medical devices industry\n<\/li>\n<li>\nInsight into recent industry structure, the competitive landscape for major types of stents manufacturers, ongoing research activities and their clinical trials\n<\/li>\n<li>\nKey merger and acquisition deals, product approvals\/launches, agreements, collaborations, and other strategic alliances within the MedTech industry\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1 Introduction<\/strong>\n<\/p>\n<p>\n<strong>Chapter 2 Summary and Highlights<\/strong>\n<\/p>\n<p>\n<strong>Chapter 3 Market and Technology Background<\/strong>\n<\/p>\n<p>\n<strong>Chapter 4 Regulatory Structure<\/strong>\n<\/p>\n<p>\n<strong>Chapter 5 Market Breakdown by Application<\/strong>\n<\/p>\n<ul>\n<li>\nOverview\n<\/li>\n<li>\nVascular\n<\/li>\n<li>\nCoronary\n<\/li>\n<li>\nPeripheral Vascular\n<\/li>\n<li>\nNonvascular\n<\/li>\n<li>\nUreteral\n<\/li>\n<li>\nGastrointestinal\n<\/li>\n<li>\nBiliary and Pancreatic\n<\/li>\n<li>\nTracheobronchial\/Pulmonary\n<\/li>\n<li>\nGlobal Market for Stents, by Therapeutic Application\n<\/li>\n<li>\nGlobal Market for Vascular Stents, by Therapeutic Application\n<\/li>\n<li>\nGlobal Market for Coronary Stents\n<\/li>\n<li>\nGlobal Market for Peripheral Vascular Stents, by Therapeutic Application\n<\/li>\n<li>\nGlobal Market for Nonvascular Stents, by Therapeutic Application\n<\/li>\n<li>\nUreteral Stents\n<\/li>\n<li>\nGastrointestinal Stents\n<\/li>\n<li>\nBiliary and Pancreatic Stents\n<\/li>\n<li>\nTracheobronchial\/Pulmonary Stents\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 6 Market Breakdown by Product Type<\/strong>\n<\/p>\n<ul>\n<li>\nOverview\n<\/li>\n<li>\nStent Material\n<\/li>\n<li>\nBare-Metal Stent (BMS)\n<\/li>\n<li>\nDrug-Eluting Stents (DES)\n<\/li>\n<li>\nDrugs Used in DES\n<\/li>\n<li>\nPolymer-Based DES\n<\/li>\n<li>\nPolymer-Free DES (PF-DES)\n<\/li>\n<li>\nBiodegradable\/Bioabsorbable Stents (BDS)\n<\/li>\n<li>\nTechnological Advantages of BDS\n<\/li>\n<li>\nTechnological Disadvantages of BDS\n<\/li>\n<li>\nOther Stents\n<\/li>\n<li>\nCovered Stents\n<\/li>\n<li>\nPlastic, Hybrid Material, and Silicone Stents\n<\/li>\n<li>\nGlobal Market for Stents, by Stent Type\n<\/li>\n<li>\nMarket Analysis\n<\/li>\n<li>\nMarket Revenue\n<\/li>\n<li>\nGlobal Market for Vascular Stents, by Stent Type\n<\/li>\n<li>\nMarket Analysis\n<\/li>\n<li>\nMarket Revenue\n<\/li>\n<li>\nGlobal Market for Coronary Stents, by Stent Type\n<\/li>\n<li>\nGlobal Market for Peripheral Vascular Stents, by Stent Type\n<\/li>\n<li>\nGlobal Market for Nonvascular Stents, by Stent Type\n<\/li>\n<li>\nMarket Analysis\n<\/li>\n<li>\nMarket Revenue\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 7 Market Breakdown by Region<\/strong>\n<\/p>\n<p>\n<strong>Chapter 8 Market Dynamics<\/strong>\n<\/p>\n<ul>\n<li>\nMarket Drivers<\/p>\n<ul>\n<li>\nFavorable Global Demographics and Aging Population\n<\/li>\n<li>\nGreater Incidence of Non-Communicable\/Chronic Diseases\n<\/li>\n<li>\nContinuous Product and Technology Developments\n<\/li>\n<\/ul>\n<\/li>\n<li>\nOther Drivers\n<\/li>\n<li>\nMarket Restraints<\/p>\n<ul>\n<li>\nAlternative Technologies\n<\/li>\n<li>\nDecline in Average Selling Prices\n<\/li>\n<li>\nStringent Regulatory Environment\n<\/li>\n<li>\nCoverage and Reimbursement Issues\n<\/li>\n<\/ul>\n<\/li>\n<li>\nOther Restraints\n<\/li>\n<li>\nMarket Trends\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 9 Competitive Landscape<\/strong>\n<\/p>\n<ul>\n<li>\nOverview\n<\/li>\n<li>\nKey Stent Manufacturers&#8217; Offerings, by Application Types\n<\/li>\n<li>\nGlobal Company Ranking\n<\/li>\n<li>\nCoronary Stents\n<\/li>\n<li>\nPeripheral Vascular Stents\n<\/li>\n<li>\nNonvascular Stents\n<\/li>\n<li>\nRecent Industry Activities\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 10 Company Profiles<\/strong>\n<\/p>\n<ul>\n<li>\nAbbott Laboratories\n<\/li>\n<li>\nB. Braun Melsungen Ag\n<\/li>\n<li>\nBecton, Dickinson And Co.\n<\/li>\n<li>\nBiosensors International\n<\/li>\n<li>\nBiotronik Se &amp; Co. Kg\n<\/li>\n<li>\nBoston Scientific Corp.\n<\/li>\n<li>\nCook Medical Llc\n<\/li>\n<li>\nCordis Corp.\n<\/li>\n<li>\nLepu Medical Technology (Beijing) Co., Ltd.\n<\/li>\n<li>\nMedtronic Plc\n<\/li>\n<li>\nTerumo Corp.\n<\/li>\n<li>\nW. L. Gore &amp; Associates, Inc.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5603759\/stents-technologies-and-global-markets-2022-2027?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=2922c6&amp;utm_campaign=1720326+-+Stents%3A+Technologies+and+Global+Markets+2022-2027%3A+Greater+Incidence+of+Non-Communicable%2FChronic+Diseases+Fueling+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/ip46n0<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;p&#114;&#x65;&#115;&#x73;&#64;&#114;&#x65;s&#x65;a&#114;&#x63;h&#x61;&#x6e;&#100;&#x6d;a&#114;&#x6b;&#101;&#x74;s&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;s&#64;&#114;&#x65;&#x73;e&#97;&#114;&#x63;&#x68;a&#110;&#x64;&#x6d;&#x61;r&#107;&#x65;&#x74;s&#46;&#99;&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Stents: Technologies and Global Markets 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027. The global market for &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45732","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\/Chronic Diseases Fueling Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\/Chronic Diseases Fueling Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Stents: Technologies and Global Markets 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027. The global market for ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-01T10:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220701005164\/en\/1503026\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\\\/Chronic Diseases Fueling Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-01T10:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/\"},\"wordCount\":735,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220701005164\\\/en\\\/1503026\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/\",\"name\":\"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\\\/Chronic Diseases Fueling Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220701005164\\\/en\\\/1503026\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-01T10:01:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220701005164\\\/en\\\/1503026\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220701005164\\\/en\\\/1503026\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\\\/Chronic Diseases Fueling Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\/Chronic Diseases Fueling Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\/Chronic Diseases Fueling Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Stents: Technologies and Global Markets 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027. The global market for ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-01T10:01:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220701005164\/en\/1503026\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\/Chronic Diseases Fueling Growth &#8211; ResearchAndMarkets.com","datePublished":"2022-07-01T10:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/"},"wordCount":735,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220701005164\/en\/1503026\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/","name":"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\/Chronic Diseases Fueling Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220701005164\/en\/1503026\/21\/logo.jpg","datePublished":"2022-07-01T10:01:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220701005164\/en\/1503026\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220701005164\/en\/1503026\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/stents-technologies-and-global-markets-2022-2027-greater-incidence-of-non-communicable-chronic-diseases-fueling-growth-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable\/Chronic Diseases Fueling Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45732"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45732\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}